Sulforidazine
From Wikipedia, the free encyclopedia
|
Sulforidazine
|
|
| Systematic (IUPAC) name | |
| 10-{2-[(RS)-1-Methylpiperidin- 2-yl]ethyl}-2- methylsulfonylphenothiazine | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C21H26N2O2S2 |
| Mol. mass | 402.575 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Sulforidazine (brand names: Imagotan, Psychoson, Inofal) a typical antipsychotic and a metabolite of thioridazine; it and mesoridazine are more potent than the parent compound, whose pharmacological effects are believed by some to be largely due to its metabolism into sulforidazine and mesoridazine.[1]
[edit] References
- ^ Niedzwiecki DM, Mailman RB, Cubeddu LX (Mar 1984). "Greater potency of mesoridazine and sulforidazine compared with the parent compound, thioridazine, on striatal dopamine autoreceptors". Journal of Pharmacology & Experimental Therapeutics 228 (3): 636–9. PMID 6707914.
- PubChem Substance Summary: Sulforidazine National Center for Biotechnology Information.
|
|||||||||||

